Outfitter Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$869K Hold
18,120
0.61% 53
2026
Q1
$666K Buy
18,120
+1,110
+7% +$52.6K 0.52% 61
2025
Q4
$865K Sell
17,010
-1,050
-6% -$53.7K 0.68% 52
2025
Q3
$1M Buy
18,060
+2,230
+14% +$131K 0.81% 44
2025
Q2
$1.09M Buy
15,830
+4,220
+36% +$287K 0.93% 41
2025
Q1
$806K Buy
11,610
+2,815
+32% +$232K 0.73% 48
2024
Q4
$757K Buy
8,795
+795
+10% +$86K 0.61% 55
2024
Q3
$953K Hold
8,000
0.79% 46
2024
Q2
$1.14M Hold
8,000
0.95% 40
2024
Q1
$1.03M Sell
8,000
-1,000
-11% -$119K 0.84% 43
2023
Q4
$931K Hold
9,000
0.81% 46
2023
Q3
$818K Hold
9,000
0.77% 52
2023
Q2
$728K Hold
9,000
0.65% 56
2023
Q1
$716K Sell
9,000
-1,000
-10% -$70.9K 0.64% 57
2022
Q4
$677K Hold
10,000
0.61% 61
2022
Q3
$498K Hold
10,000
0.49% 62
2022
Q2
$557K Sell
10,000
-4,000
-29% -$222K 0.51% 66
2022
Q1
$777K Hold
14,000
0.59% 63
2021
Q4
$784K Hold
14,000
0.58% 58
2021
Q3
$672K Hold
14,000
0.53% 67
2021
Q2
$586K Hold
14,000
0.45% 73
2021
Q1
$472K Sell
14,000
-950
-6% -$33.8K 0.39% 77
2020
Q4
$522K Buy
+14,950
New +$517K 0.5% 67

Other funds holding NVO

Outfitter Financial's NVO Position: Q2 2026 in Review

Outfitter Financial held its Novo Nordisk (NVO) position steady in Q2 2026 at 18,120 shares worth $869K. The position accounts for 0.61% of the portfolio, ranked #53.

Outfitter Financial first reported a position in NVO in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.14M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Outfitter Financial held 18,120 shares of Novo Nordisk worth $869K as of Q2 2026.
  • Outfitter Financial left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.61% of Outfitter Financial's portfolio in Q2 2026, its #53 holding.
  • Outfitter Financial first reported a position in Novo Nordisk in Q4 2020 and has held it in 23 quarters since.
  • Outfitter Financial's Novo Nordisk position peaked at $1.14M in Q2 2024.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Outfitter Financial's 13F filing for Q2 2026, filed 10 Aug 2026.